In conclusion, this study shows that in NSCLC, the SUVmax for 18F-FDG PET/CT is significantly associated with that of PD-L1 expression, at the 1% cutoff value for assessing through immunostaining with the SP142 antibody. This evidence concerns the gene CD274 and non-small cell lung carcinoma.